← Natural Eye Care

Drusen: what they are, and when they can clear

By Dr. Glen Swartwout, Naturopathic Optometrist

I am retired from licensed practice, and I now write and teach about natural eye care.

This page is education, not a diagnosis or a treatment plan.

Drusen are small yellow deposits that build up under the retina.

Small hard drusen are common with age and often harmless.

Larger soft drusen are a sign of macular degeneration and of higher risk.

Many people are told drusen only grow.

The research says something more hopeful, and more careful.

What drusen are made of

The retina's support layer is called the retinal pigment epithelium.

It sends fats out toward the blood supply behind the eye.

With age, the membrane it sends them through thickens and the fats back up.

One researcher describes a "major ultrastructural component" of soft drusen as cholesterol-rich lipoproteins from that layer.

Source: Soft Drusen in Age-Related Macular Degeneration: Biology and Targeting Via the Oil Spill Strategies

She calls macular degeneration "a vascular-metabolic-inflammatory disease."

Source: Soft Drusen in Age-Related Macular Degeneration: Biology and Targeting Via the Oil Spill Strategies

Another team proposed that cell debris seeds a deposit and inflammation then builds around it.

Source: A role for local inflammation in the formation of drusen in the aging eye

Drusen and Alzheimer's disease

Amyloid beta is a protein fragment best known from the brain plaques of Alzheimer's disease.

It has also been found in some drusen.

One team found it "associated with a substructural vesicular component within drusen."

Source: The Alzheimer's A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration

A small study of donor eyes found it in "4 of 9 AMD eyes."

It was found in "None of the 9 normal eyes surveyed."

Some of those normal eyes had small drusen without it.

The authors said more work is needed to know whether it causes damage or results from it.

Source: Amyloid-beta is found in drusen from some age-related macular degeneration retinas, but not in drusen from normal retinas

Another team found "nonfibrillar, toxic oligomers in drusen."

These are small clumps of misfolded protein, like those studied in Alzheimer's disease.

The test detects a shared shape and did not identify the protein.

Source: Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers

One review says the deposits in the two diseases have "many similarities."

It adds that "it seems that these diseases have a different genetic background."

Source: Age-related macular degeneration (AMD): Alzheimer's disease in the eye?

Some studies asked whether macular degeneration predicts dementia.

They did not ask this of ordinary drusen that come with age.

Their results disagree.

A Dutch study of 1438 people aged 75 or older saw raised Alzheimer's risk with advanced disease.

That link weakened and lost significance after allowing for smoking and hardened arteries.

Source: Is age-related maculopathy associated with Alzheimer's Disease? The Rotterdam Study

English hospital records of 65894 people found the risk of dementia after macular degeneration "was not elevated."

Source: Associations between age-related macular degeneration, Alzheimer disease, and dementia: record linkage study of hospital admissions

A 2023 review of eight studies found about a 22 percent higher dementia risk.

The link was stronger in dry macular degeneration.

A link like this cannot show that one disease causes the other.

Source: Macular degeneration and later dementia or Alzheimer disease, a meta-analysis, American Journal of Ophthalmology, 2023

A drug that targets amyloid has been tested in late dry macular degeneration.

In 191 people, it "did not reduce the rate of GA enlargement relative to placebo."

GA stands for geographic atrophy, the late dry stage.

Source: A Randomized Phase 2 Study of an Anti-Amyloid β Monoclonal Antibody in Geographic Atrophy Secondary to Age-Related Macular Degeneration

One carnosine study used only retinal cells grown in a dish.

In retinal cells exposed to amyloid, it countered "most of the molecular alterations."

I found no human study of carnosine for drusen.

Source: Carnosine Counteracts the Molecular Alterations Aβ Oligomers-Induced in Human Retinal Pigment Epithelial Cells

Drusen can shrink

Eye scans that measure drusen over time show they do not only grow.

One study measured drusen volume over a year.

It "increased in 48% of eyes, remained stable in 40%, and decreased in 12%".

Source: Natural history of drusen morphology in age-related macular degeneration using spectral domain optical coherence tomography

Over two years, another study found some regression in about half of the eyes it followed.

Those areas often showed changes on a second kind of scan, called autofluorescence.

Source: Drusen regression is associated with local changes in fundus autofluorescence in intermediate age-related macular degeneration

Shrinking is not always healing

Drusen sometimes shrink just before macular degeneration reaches its late stage.

In one study, drusen regressed in 22 of 50 eyes.

Four of those eyes then grew leaky new vessels, and three developed atrophy.

The authors concluded: "Spontaneous regression appears to precede conversion to advanced AMD."

Source: Drusen volume development over time and its relevance to the course of age-related macular degeneration

So a smaller deposit on its own proves nothing.

In my view, healing looks different.

The drusen shrink and the retina over them stays intact.

Vision holds or improves.

Studies show drusen can shrink without atrophy.

These studies measured the scans and retinal function, not whether vision improved.

A 2025 study found regression without atrophy in "24.17% of the eyes" it followed with soft drusen.

Most of those regressions sat next to another druse that did collapse with atrophy.

Source: Spontaneous Soft Drusen Regression without Atrophy and the Drusen Ooze

A study of 14 people found soft drusen can fade with no detectable local loss of function.

Their retinas were still less sensitive overall than those of healthy people.

The authors warn that this fading is "a potential source of misclassification."

Source: Functional aspects of drusen regression in age-related macular degeneration

True clearing can only be shown by scans and vision tests over time.

What research has tried

Very few treatment studies have measured drusen directly.

In a small high-dose statin study, 23 people completed a year.

Ten of them had drusen regress.

The study had no comparison group.

The authors called for "Confirmation from larger studies."

Source: Regression of Some High-risk Features of Age-related Macular Degeneration (AMD) in Patients Receiving Intensive Statin Treatment

A study of 3,791 people found statin use was not linked with slower progression to late disease.

Source: The Association of Statin Use with Age-Related Macular Degeneration Progression: The Age-Related Eye Disease Study 2 Report Number 9

Laser can reduce drusen.

It did not reduce the risk of leaky new vessels.

It was not shown to limit atrophy or vision loss.

Source: Laser treatment of drusen to prevent progression to advanced age-related macular degeneration

People who ate closer to a Mediterranean diet were less likely to progress to large drusen or late disease.

In one of the two groups, the benefit appeared mainly in people with certain protective genes.

That study did not measure regression.

Source: Adherence to the Mediterranean Diet and Progression to Late Age-Related Macular Degeneration in the Age-Related Eye Disease Studies 1 and 2

How I think about drusen

What follows is my own view, from many years in natural eye care.

It is not proven by the studies above.

I see drusen as a waste problem, where the eye takes in more than it can clear.

Researchers have compared the inflammation in drusen to that in Alzheimer's disease and atherosclerosis.

Source: A role for local inflammation in the formation of drusen in the aging eye

I see a parallel there too.

I see amyloid in drusen as very similar to amyloid in the brain.

The studies above show some shared proteins in the deposits.

They do not show a shared disease.

I believe sugar damage to proteins plays a large part.

That damage is called glycation.

I have nicknamed macular degeneration "diabetes type four" to make that point.

It does not mean macular degeneration is a form of diabetes.

I also believe the liver matters, because it processes fats.

Circulation matters too, because the retina uses a great deal of oxygen.

So the approaches I teach aim to address four things.

None of these four approaches has been shown in a trial to clear drusen.

What to ask your eye doctor

If you have drusen, the only way to know what is happening is to measure it.

Ask for an OCT scan that measures drusen volume, and keep the reports.

Ask whether the retina over any shrinking drusen is intact.

Track your vision with the same chart each time.

Repeat the scans on the same machine at regular intervals.

Keep working with your own eye doctor throughout.